Daniel Bensen - Sep 6, 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Operating Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Sep 6, 2022
Transactions value $
$0
Form type
4
Date filed
9/8/2022, 05:36 PM
Previous filing
Nov 4, 2021
Next filing
Mar 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +105K $0.00 105K Sep 6, 2022 Common Stock 105K $7.14 Direct F1
transaction TYRA Stock Option (Right to Buy) Award $0 +250K $0.00 250K Sep 6, 2022 Common Stock 250K $7.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F2 1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.